SCHEMBL31715853

SCHEMBL31715853

Cc1ccc(C(=O)NNC(=O)c2cc(F)c(O)c(F)c2)cc1NCc1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 9/20 0.54
▸ HDAC1 Q13547 4/20 0.53
▸ HDAC6 Q9UBN7 4/20 0.53
▸ MAPT P10636 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ BCHE P06276 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ SSTR3 P32745 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ DDR2 Q16832 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ DDR1 Q08345 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716167 0.78 HDAC8 (0.54) HDAC8HDAC1HDAC6MAPTSMN1; SMN2
SCHEMBL31715865 0.70 MEN1 (0.40) HDAC8MAPTSMN1; SMN2MEN1LMNA
SCHEMBL31716514 0.70 NPC1 (0.45) HDAC8HDAC1HDAC6MAPTSMN1; SMN2
SCHEMBL31716202 0.70 HDAC8 (0.43) HDAC8HDAC1HDAC6MAPTSMN1; SMN2
SCHEMBL29355265 0.70 HDAC8 (1.00) HDAC8HDAC1HDAC6
SCHEMBL31716496 0.65 POLB (0.46) HDAC8HDAC1HDAC6MAPTSMN1; SMN2
SCHEMBL12871405 0.65 HDAC8 (0.56) HDAC8HDAC1HDAC6MAPTSMN1; SMN2
SCHEMBL31215396 0.64 HDAC8 (0.50) HDAC8HDAC1HDAC6L3MBTL1
SCHEMBL20236173 0.64 POLB (0.54) HDAC8HDAC1HDAC6SMN1; SMN2GAA
SCHEMBL7150575 0.64 HDAC8 (0.66) HDAC8HDAC1HDAC6MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025224512-A1 NOVEL COMPOUND AS 17-BETA-HYDROXYSTEROID DEHYDROGENASE 13 (HSD17B13) INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 삼진제약주식회사 2025-10-30 — — WO disclosed
Send feedback